1571213-89-2

Basic information

• Product Name: 4-(2-bromo-4-fluorophenyl)-2-(4-(2-methoxy-2-oxoethyl)thiazole-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylic acid ethyl ester
• Synonyms: 4-(2-bromo-4-fluorophenyl)-2-(4-(2-methoxy-2-oxoethyl)thiazole-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylic acid ethyl ester
• CAS NO: 1571213-89-2
• Molecular Weight: 496.357
• Mol File: 1571213-89-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(2-bromo-4-fluorophenyl)-2-(4-(2-methoxy-2-oxoethyl)thiazole-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-bromo-4-fluorophenyl)-2-(4-(2-methoxy-2-oxoethyl)thiazole-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylic acid ethyl ester(1571213-89-2)
• EPA Substance Registry System: 4-(2-bromo-4-fluorophenyl)-2-(4-(2-methoxy-2-oxoethyl)thiazole-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylic acid ethyl ester(1571213-89-2)

Safety Data

• Hazardous Substances Data: 1571213-89-2(Hazardous Substances Data)

Upstream product

• 59142-68-6 2-bromo-4-fluorobenzaldehyde 
• 141-97-9 ethyl acetoacetate 

Downstream Products

• 1571213-91-6 4-(2-bromo-4-fluorophenyl)-6-(bromomethyl)-2-(4-(2-methoxy-2-oxoethyl)thiazole-2-yl)-1,4-dihydropyrimidine-5-carboxylic acid ethyl ester 

Relevant articles and documents

Dihydropyrimidine compounds and their use in medicine

The invention relates to dihydropyrimidine compounds and application thereof in medicines, particularly application in medicines for treating and preventing hepatitis B. Particularly, the invention relates to compounds disclosed as general formula (I) or (Ia), or enantiomers, diastereoisomers, tautomerides, hydrates, solvates or pharmaceutically acceptable salts thereof, wherein the variables are defined in the specification. The invention also relates to application of the compounds disclosed as general formula (I) or (Ia), or enantiomers, diastereoisomers, tautomerides, hydrates, solvates or pharmaceutically acceptable salts thereof, especially application in medicines for treating and preventing hepatitis B.